Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desflurane vs Propofol on Hemostasis in Splenectomy with Liver Cirrhosis
NCT02079064Completed
- Sponsor
- Theodor Bilharz Research Institute
- Start
- Jan 2014
- Primary completion
- Jun 2017
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Randomised, open-label trial of desflurane and propofol injection (veterinary) in Liver cirrhosis (LC) (2 arms), sponsored by Theodor Bilharz Research Institute. Primary endpoint: Maximum Clot Firmness up to 1 month. Started Jan 2014; status: completed.
02
Drugs
desfluranepropofol injection (veterinary)
03
Conditions
Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT02079064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02079064.